1-butyl-2,3-dimethylimidazolium bis(trifluoromethylsulfonyl)imide Synonyms

We are 1-butyl-2,3-dimethylimidazolium bis(trifluoromethylsulfonyl)imide Synonyms CAS:350493-08-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests


English Name: 1-butyl-2,3-dimethylimidazolium bis(trifluoromethylsulfonyl)imide
Synonyms
1-Butyl-2,3-diMethyliMidazoliuMBis(trifluoroMethanesulfonyl)iMide
1-n-butyl-2,3-dimethylimidazolium bistrifluoromethylsulfonylamide
Molecular Formula: C11H17N3F6O4S2
Molecular Weight: 433.39
CAS No.: 350493-08-2
Purity: 99%
 
Technical Information

Appearance: colorless liquid	Purity: 99%
NMR: Passed	null
Solubility: dichloromethane,	Insolubility: water, ether, ethyl acetate,
Impurity content: (1) dimethylimidazole content: < 1000 ppm; (2) Halogen content: < 1000 ppm; (3) Water content: < 1000 ppm

 
Physics-Chemistry Properties

Melting point: -76.0℃(Tg)	Decomposition temperature: 430℃
Conductivity: 1.65mS/cm	Electrochemical window:
Viscosity: 97cp	Density: 1.421g/cm3

 
Our company has been engaged in the R&D, production of ionic liquids and related technologies for more than ten years. Since 2007, our company has supplied ionic liquid reagents to customers, and can provide customers with ionic liquid products from grams to hundreds of tons. The main product series are: Imidazolium ionic liquids, single-substituted Im ionic liquids, Disubstituted Im ionic liquids, Tri-Substituted Im ionic liquids, Pyrilidinium ionic liquids, Ammonium ionic liquids, Phosphonium ionic liquids, Pyrrolidinium ionic liquids, Piperidinium ionic liquids, Functionized ionic liquids, Vinyl-Based ionic liquids, Hydroxyl-Based ionic liquids, Ether-Based ionic liquids, Ester-Based ionic liquids, Carboxyl-Based ionic liquids, Nitrile-Based ionic liquids, Amido-Based ionic liquids, SulfoAcid-Based ionic liquids, Benzyl-Based ionic liquids, Guanidine-Based ionic liquids, Oxonium salts



Related News: From the perspective of the overall life cycle of generic drugs from R & D to sales, with the expiration of patents, the business model for the production and marketing of generic pharmaceutical raw materials has changed, demand has increased, business potential has been realized quickly, and gross profit margins have shown a downward trend.(R,E)-5-([1,1'-biphenyl]-4-yl)-4-((tert-butoxycarbonyl)amino)-2-methylpent-2-enoic acid CAS:1012341-48-8 We have leading expertise in strategy and operational implementation of pre-approval access programs making pharmaceutical products under clinical development available for patients and Inceptua’s clinical trial services business offers high quality clinical comparator sourcing and manufacturing services with an agile global supply chain to ensure that products are delivered exactly when needed.3-Fluoro-2-methoxybenzaldehyde CAS:74266-68-5 We have leading expertise in strategy and operational implementation of pre-approval access programs making pharmaceutical products under clinical development available for patients and Inceptua’s clinical trial services business offers high quality clinical comparator sourcing and manufacturing services with an agile global supply chain to ensure that products are delivered exactly when needed.2-Bromotriphenylene Advanced intermediate suppliers not only have strong bargaining power for junior suppliers, but more importantly, because they undertake the production of advanced intermediates with high technical content and maintain closer ties with multinational companies, raw materials Price fluctuations have little effect on it.At Day 35 following administration, a bone marrow assessment showed that FT819 persisted and continued to demonstrate tumor clearance, whereas primary CAR T cells, while persisting, were not able to control tumor growth.